Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,112.68
(
-0.34%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
95.50
(
3.30%
)
Bitcoin
72,986.57
(
-2.54%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123029
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 221975

Friday, 02/01/2019 3:54:15 PM

Friday, February 01, 2019 3:54:15 PM

Post# of 257648
ONCS down again on KEYNOTE-695 data in second-line melanoma:

https://www.sec.gov/Archives/edgar/data/1444307/000149315219001233/ex99-1.htm

The ORR is now 23.8% (5/21); inasmuch as the ORR was 22.2% (2/9) at the 2018-SITC interim (#msg-144697253), there have been 3 new responders among the 12 newly evaluable patients.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today